Evaluating a Digital Intervention to Improve Resilience and Reduce Stress in Stanford Populations (SIER-WONE)
Evaluating a Digital Intervention to Improve Resilience and Reduce Stress in Stanford Populations (SIER Study)
High-achieving academic and entrepreneurial populations face elevated risks of chronic stress, anxiety, and burnout. These populations often underutilize mental health services due to stigma, time constraints, or accessibility issues. Digital interventions provide an opportunity to deliver evidence-based stress and resilience support at scale.
The WONE (Walking on Earth, Ltd.) platform integrates personalized stress-resilience assessments, behavioral science micro-interventions, and optional wearable data feedback. This project aims to evaluate the feasibility, engagement, and preliminary efficacy of the WONE digital intervention in multiple Stanford-affiliated cohorts.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Primary Objective To evaluate whether engagement with the WONE app improves resilience, emotional well-being, and stress management outcomes among Stanford-affiliated adults.
Secondary Objective To evaluate the feasibility of wearable-device integration.
Rationale for Two-Phase Structure This protocol includes two sequential studies.
- Phase 1 (Pilot): A single-arm feasibility pilot designed to assess acceptability of the WONE digital intervention, verify that onboarding, survey workflows, and data capture function smoothly, and identify any usability issues before running a randomized trial.
- Phase 2 (Randomized Crossover RCT): A fully powered evaluation of the efficacy of WONE, using a 12-week crossover design to compare intervention vs. control periods, followed by a 6-month follow-up to evaluate maintenance of effects.
Phase 1 Objectives (Pilot)
- Assess feasibility and acceptability of the WONE digital intervention over 8 weeks.
- Evaluate preliminary changes in resilience, emotional well-being, and stress management from baseline to Week 8. Secondary analysis will also explore changes in symptoms related to anxiety and depression.
- Describe engagement patterns and examine whether engagement relates to changes in outcomes.
- Assess feasibility of wearable integration, including connection rates and data completeness.
Phase 2 Objectives (Randomized Crossover RCT)
- Test the efficacy of the WONE intervention compared to a control period using a 12-week crossover design.
- Examine changes in resilience, emotional well-being, and stress management across intervention vs. control phases. Secondary analysis will also explore changes in symptoms related to anxiety and depression.
- Investigate engagement as a predictor of improvement.
- Evaluate maintenance of effects at the 6-month follow-up.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Chloe Yeung
- Telefonnummer: 6502450094
- E-post: cayeung@stanford.edu
Studer Kontakt Backup
- Navn: Alan Yeung, MD
- Telefonnummer: 6507282619
- E-post: ayeung@stanford.edu
Studiesteder
-
-
California
-
Stanford, California, Forente stater, 94305
- Stanford School of Medicine
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Aged between 18 and 65 years with Stanford affiliation
- English proficiency with the ability to read, write, and complete surveys in English
- Smartphone with internet access
- Willingness to complete surveys and app activities
- Resides in the US
- Stanford affiliation
- Wearable device for Phase 1 Pilot Study
Exclusion Criteria:
Severe psychiatric instability, defined as any of the following self-reported on the pre-enrollment screener:
- Psychiatric hospitalization for a mental health crisis in the past 12 months.
- Current mental health symptoms that significantly impair ability to function in daily life (e.g., unable to work, attend school, or care for basic needs).
- No smartphone or unwilling to consent.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Phase 2: Control (Weeks 1-12) then Intervention (Weeks 13-24)
Arm A: The control and intervention conditions are delivered via two separate versions of the WONE mobile application: 1.
Control WONE app (limited version) - used during control periods 2. Intervention WONE app (full version) - used during intervention periods.
At baseline, participants download the Control version.
At Week 12, participants receive instructions via email to download the alternate Intervention version.
The participants are blinded to the sequence.
|
The Intervention WONE app (Full version) has the following features:
|
|
Annen: Phase 2: Intervention (Weeks 1-12) then Control (Weeks 13-24)
Arm B: The control and intervention conditions are delivered via two separate versions of the WONE mobile application: 1. Intervention WONE app (full version) - used during intervention periods.
2. Control WONE app (limited version) - used during control periods.
At baseline, participants download the Intervention version.
At Week 12, participants receive instructions via email to download the alternate Control version.
Participants are blinded to the sequence.
|
The Intervention WONE app (Full version) has the following features:
|
|
Annen: Phase 1 (pilot, single arm)
Participants will download the web application for 8 weeks and asked to complete the WONE assessments and use the app for more than 3 times per week and complete week 4 and 8 endpoints assessments.
|
The Intervention WONE app (Full version) has the following features:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Phase 1: Change in Walking on Earth Index (WONE) Index
Tidsramme: Baseline, week 4, week 8
|
WONE index is a 50-item validated measure of psychosocial resilience, recently validated against the Connor-Davidson Resilience Scale and the Brief Resilience Scale. Higher scores indicate greater resilience and well-being. |
Baseline, week 4, week 8
|
|
Phase 2: Change in WONE Index
Tidsramme: Baseline, week 4, week 8, week 12, week 16, week 20, week 24
|
WONE index is a 50-item validated measure of psychosocial resilience.
Higher scores indicate greater resilience and well-being.
|
Baseline, week 4, week 8, week 12, week 16, week 20, week 24
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Alan Yeung, MD, Stanford University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 84749
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .